CYTOKINETICS INCORPOR

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 أبريل 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis

31 مارس 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Releases Inaugural Corporate Responsibility Report

27 مارس 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Cytokinetics to Participate in Upcoming Investor Conferences

06 مارس 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session

04 مارس 2023 10:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 مارس 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Reports Fourth Quarter 2022 Financial Results

01 مارس 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Receives Complete Response Letter From FDA for New Drug Application for Omecamtiv Mecarbil

28 فبراير 2023 17:31:51 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Three Upcoming Presentations at the American College of Cardiology 72nd Annual Scientific Session

24 فبراير 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

22 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Cytokinetics to Announce Fourth Quarter Results on March 1, 2023

15 فبراير 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 فبراير 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program

30 يناير 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 يناير 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

03 يناير 2023 16:00:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil

13 ديسمبر 2022 17:45:52 بحسب Nasdaq GlobeNewswire

Cytokinetics Stock Trading Halted Today

13 ديسمبر 2022 07:02:16 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

09 ديسمبر 2022 08:59:34 بحسب Nasdaq GlobeNewswire

Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND

08 ديسمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136

07 ديسمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire